SPNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SiriusPoint Ltd (SPNT) is not a strong buy for a beginner investor with a long-term focus at this time. While the company has shown improvements in financial strength and restructuring efforts, the recent financial performance shows a sharp decline in net income and EPS, which raises concerns. Additionally, the pre-market price drop and lack of strong trading signals suggest that waiting for more favorable conditions or further clarity on growth prospects would be prudent.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral, and moving averages are bullish. The stock is trading near its pivot level of 21.186, with resistance at 22.223 and support at 20.149. However, the pre-market price drop of -0.85% suggests some weakness.
Fitch upgraded SiriusPoint's financial strength rating to A and its issuer default rating to BBB+, citing significant improvements in earnings and financial position. The company has strategically repositioned its insurance portfolio and exited non-core lines, strengthening its capitalization.
Net income and EPS have dropped significantly in the latest quarter, raising concerns about profitability. Analysts have highlighted near-term risks from catastrophe losses and weak pricing, which may limit growth and margin expansion.
In Q4 2025, revenue increased by 44.94% YoY to $973.7 million, but net income dropped by -1448.31% YoY to $240 million. EPS also declined sharply by -1890.91% YoY to 1.97, indicating significant profitability challenges.
Raymond James initiated coverage with a Market Perform rating, citing improved earnings quality and underwriting profitability but noting that much of the progress is already reflected in the valuation. Near-term risks from catastrophe losses and weak pricing are highlighted as concerns.
